Skip to main content
Amoy Diagnostics Co.,Ltd. logo

Amoy Diagnostics Co.,Ltd. — Investor Relations & Filings

Ticker · 300685 ISIN · CNE1000034D3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,088 across all filing types
Latest filing 2022-05-11 Share Issue/Capital Cha…
Country CN China
Listing Shenzhen Stock Exchange 300685

About Amoy Diagnostics Co.,Ltd.

https://www.amoydx.com

Amoy Diagnostics Co., Ltd. specializes in the development and commercialization of molecular diagnostic products for precision oncology. The company provides a comprehensive portfolio of testing kits designed to identify genetic mutations and biomarkers essential for personalized cancer treatment. Its core technology platforms include the proprietary ADx-ARMS, Super-ARMS, and specialized Next-Generation Sequencing (NGS) solutions. AmoyDx focuses on companion diagnostics (CDx), collaborating extensively with global pharmaceutical companies to integrate diagnostic testing into clinical drug development and patient management. Key products cover a wide range of solid tumors, including lung, colorectal, and breast cancers, facilitating targeted therapy selection and monitoring. The company maintains rigorous quality standards, with numerous products receiving regulatory approvals for clinical use in multiple international markets.

Recent filings

Filing Released Lang Actions
关于回购注销部分限制性股票减资通知债权人的公告
Share Issue/Capital Change Classification · 95% confidence The document is a public announcement by a company regarding the repurchase and cancellation of part of its restricted stock, which leads to a reduction in registered capital. It includes a notification to creditors about their rights in relation to this capital reduction. The document references a previous announcement and provides legal context for the capital change. It is not a full financial report, audit, or earnings release, but rather a specific announcement about a capital change due to share repurchase and cancellation. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is short and it contains substantive information about the capital change, not just a report publication notice or regulatory filing. Hence, the classification is SHA with high confidence.
2022-05-11 Chinese
2021年度股东大会法律意见书
AGM Information Classification · 100% confidence The document is a legal opinion letter from a law firm regarding the legality and compliance of the 2021 Annual General Meeting (AGM) of Xiamen Aide Biomedical Technology Co., Ltd. It details the convening, attendance, voting procedures, and results of the 2021 AGM. The document does not contain the actual annual report or financial statements but rather confirms the proper conduct and validity of the AGM and its resolutions. This type of document is typically classified as AGM Information (AGM-R), as it relates to materials shared or issued in connection with the AGM, specifically a legal opinion on the AGM proceedings.
2022-05-11 Chinese
关于2019年限制性股票激励计划首次授予部分第三个解除限售期解除限售股份上市流通的提示性公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the unlocking and listing of restricted shares under a 2019 restricted stock incentive plan. It includes specifics about the number of shares, conditions for unlocking, board and supervisory meetings, legal opinions, and financial advisor reports. The document is not a full financial report, earnings release, or management discussion, but rather a regulatory announcement about share unlocking and listing related to stock incentives. It does not fit categories like Annual Report, Earnings Release, or Management Reports. It is also not a simple brief announcement but a comprehensive disclosure about share unlocking and related corporate actions. This type of document aligns best with Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2022-05-11 Chinese
关于2019年限制性股票激励计划预留授予部分第二个解除限售期解除限售股份上市流通的提示性公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the unlocking and listing of restricted shares under the company's 2019 restricted stock incentive plan. It includes specifics about the number of shares, conditions for unlocking, board and supervisory committee approvals, legal opinions, and financial advisor reports. The document is not a full annual or interim financial report, nor is it a transcript, audit report, or earnings release. It is a regulatory announcement about the lifting of restrictions on stock incentives and the related share circulation. This fits best under the category of Regulatory Filings (RNS), as it is a formal disclosure related to share incentive plans and share circulation but does not constitute a financial report or other specific filing type.
2022-05-05 Chinese
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase plan. It details the number of shares repurchased, prices, compliance with regulations, and future intentions to continue the buyback. It does not contain financial statements or comprehensive financial data, nor is it a full report. The document is relatively short (1333 characters) and focuses on the update of the share buyback activity. Therefore, it fits the category of 'Transaction in Own Shares' (POS), which covers reports of the company buying back its own shares.
2022-05-05 Chinese
关于举行2021年度网上业绩说明会暨参加厦门辖区上市公司投资者网上集体接待日活动的公告
Report Publication Announcement Classification · 95% confidence The document is an announcement about holding a 2021 annual performance explanation meeting and participation in an investor online reception event. It references that the 2021 annual report has already been disclosed on April 12, 2022, and this announcement is to inform investors about the upcoming performance explanation meeting scheduled for May 10, 2022. The document is short (888 characters) and does not contain actual financial data or detailed financial statements. It serves as a notice or invitation for an event related to discussing the annual report, not the report itself. Therefore, it fits the category of Report Publication Announcement (RPA) rather than the Annual Report (10-K) or Investor Presentation (IP).
2022-04-26 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.